FindTrial
Sign In

Oral nicorandil given in off pump coronary artery bypass graft patients reduces acute kidney injury

Role of oral nicorandil in prevention of AKI in off pump CABG patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045380
Enrollment
400
Registered
2022-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Nicorandil: The study involves complete assessment of patients by Cleveland score and select the patients with a score of more than or equal to 3.We will give nicorandil 10 mg oral rout

Sponsors

UNMehta Institute of Cardiology and Research center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who undergo off pump CABG with cleveland score more than or equal to 3. 2)Patients who were already using nicorandil and stopped for more than 7 days. 3)Patients were undergoing isolated off-pump coronary artery bypass grafting surgery. 4)Signed informed consent

Exclusion criteria

Exclusion criteria: 1)Patients who were converted from off pump to on pump CABG 2)Patients who were already using nicorandil till the day of surgery 3)Patients who undergo off pump CABG with cleveland score less than 3

Design outcomes

Primary

MeasureTime frame
the relationship of oral nicorandil in prevention of AKI in off -pump CABG patientsTimepoint: Assess the patients at 1 week before discharge—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactPaidi Siva Rama Krishna

U N MEHTA INSTITUTE OF CARDIOLOGY AND RESEARCH CENTRE

drkartikpgi@yahoo.com9925249221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026